MIT Research News' Journal
 
[Most Recent Entries] [Calendar View]

Monday, October 7th, 2019

    Time Event
    11:09a
    New capsule can orally deliver drugs that usually have to be injected

    Many drugs, especially those made of proteins, cannot be taken orally because they are broken down in the gastrointestinal tract before they can take effect. One example is insulin, which patients with diabetes have to inject daily or even more frequently.

    In hopes of coming up with an alternative to those injections, MIT engineers, working with scientists from Novo Nordisk, have designed a new drug capsule that can carry insulin or other protein drugs and protect them from the harsh environment of the gastrointestinal tract. When the capsule reaches the small intestine, it breaks down to reveal dissolvable microneedles that attach to the intestinal wall and release drug for uptake into the bloodstream.

    “We are really pleased with the latest results of the new oral delivery device our lab members have developed with our collaborators, and we look forward to hopefully seeing it help people with diabetes and others in the future,” says Robert Langer, the David H. Koch Institute Professor at MIT and a member of the Koch Institute for Integrative Cancer Research.

    In tests in pigs, the researchers showed that this capsule could load a comparable amount of insulin to that of an injection, enabling fast uptake into the bloodstream after the microneedles were released.

    Langer and Giovanni Traverso, an assistant professor in MIT’s Department of Mechanical Engineering and a gastroenterologist at Brigham and Women’s Hospital, are the senior authors of the study, which appears today in Nature Medicine. The lead authors of the paper are recent MIT PhD recipient Alex Abramson and former MIT postdoc Ester Caffarel-Salvador.

    Microneedle delivery

    Langer and Traverso have previously developed several novel strategies for oral delivery of drugs that usually have to be injected. Those efforts include a pill coated with many tiny needles, as well as star-shaped structures that unfold and can remain in the stomach from days to weeks while releasing drugs.

    “A lot of this work is motivated by the recognition that both patients and health care providers prefer the oral route of administration over the injectable one,” Traverso says.

    Earlier this year, they developed a blueberry-sized capsule containing a small needle made of compressed insulin. Upon reaching the stomach, the needle injects the drug into the stomach lining. In the new study, the researchers set out to develop a capsule that could inject its contents into the wall of the small intestine.

    Most drugs are absorbed through the small intestine, Traverso says, in part because of its extremely large surface area --- 250 square meters, or about the size of a tennis court. Also, Traverso noted that pain receptors are lacking in this part of the body, potentially enabling pain-free micro-injections in the small intestine for delivery of drugs like insulin.

    To allow their capsule to reach the small intestine and perform these micro-injections, the researchers coated it with a polymer that can survive the acidic environment of the stomach, which has a pH of 1.5 to 3.5. When the capsule reaches the small intestine, the higher pH (around 6) triggers it to break open, and three folded arms inside the capsule spring open.

    Each arm contains patches of 1-millimeter-long microneedles that can carry insulin or other drugs. When the arms unfold open, the force of their release allows the tiny microneedles to just penetrate the topmost layer of the small intestine tissue. After insertion, the needles dissolve and release the drug.

    “We performed numerous safety tests on animal and human tissue to ensure that the penetration event allowed for drug delivery without causing a full thickness perforation or any other serious adverse events,” Abramson says.

    To reduce the risk of blockage in the intestine, the researchers designed the arms so that they would break apart after the microneedle patches are applied.

    The new capsule represents an important step toward achieving oral delivery of protein drugs, which has been very difficult to do, says David Putnam, a professor of biomedical engineering and chemical and biomolecular engineering at Cornell University.
     
    “It’s a compelling paper,” says Putnam, who was not involved in the study. “Delivering proteins is the holy grail of drug delivery. People have been trying to do it for decades.”

    Insulin demonstration

    In tests in pigs, the researchers showed that the 30-millimeter-long capsules could deliver doses of insulin effectively and generate an immediate blood-glucose-lowering response. They also showed that no blockages formed in the intestine and the arms were excreted safely after applying the microneedle patches.

    “We designed the arms such that they maintained sufficient strength to deliver the insulin microneedles to the small intestine wall, while still dissolving within several hours to prevent obstruction of the gastrointestinal tract,” Caffarel-Salvador says.

    Although the researchers used insulin to demonstrate the new system, they believe it could also be used to deliver other protein drugs such as hormones, enzymes, or antibodies, as well as RNA-based drugs.

    “We can deliver insulin, but we see applications for many other therapeutics and possibly vaccines,” Traverso says. “We’re working very closely with our collaborators to identify the next steps and applications where we can have the greatest impact.”

    The research was funded by Novo Nordisk and the National Institutes of Health. Other authors of the paper include Vance Soares, Daniel Minahan, Ryan Yu Tian, Xiaoya Lu, David Dellal, Yuan Gao, Soyoung Kim, Jacob Wainer, Joy Collins, Siddartha Tamang, Alison Hayward, Tadayuki Yoshitake, Hsiang-Chieh Lee, James Fujimoto, Johannes Fels, Morten Revsgaard Frederiksen, Ulrik Rahbek, and Niclas Roxhed.

    11:09a
    A new mathematical approach to understanding zeolites

    Zeolites are a class of natural or manufactured minerals with a sponge-like structure, riddled with tiny pores that make them useful as catalysts or ultrafine filters. But of the millions of zeolite compositions that are theoretically possible, so far only about 248 have ever been discovered or made. Now, research from MIT helps explain why only this small subset has been found, and could help scientists find or produce more zeolites with desired properties.

    The new findings are being reported this week in the journal Nature Materials, in a paper by MIT graduate students Daniel Schwalbe-Koda and Zach Jensen, and professors Elsa Olivetti and Rafael Gomez-Bombarelli.

    Previous attempts to figure out why only this small group of possible zeolite compositions has been identified, and to explain why certain types of zeolites can be transformed into specific other types, have failed to come up with a theory that matches the observed data. Now, the MIT team has developed a mathematical approach to describing the different molecular structures. The approach is based on graph theory, which can predict which pairs of zeolite types can be transformed from one to the other.

    This could be an important step toward finding ways of making zeolites tailored for specific purposes. It could also lead to new pathways for production, since it predicts certain transformations that have not been previously observed. And, it suggests the possibility of producing zeolites that have never been seen before, since some of the predicted pairings would lead to transformations into new types of zeolite structures.

    Interzeolite tranformations

    Zeolites are widely used today in applications as varied as catalyzing the “cracking” of petroleum in refineries and absorbing odors as components in cat litterbox filler. Even more applications may become possible if researchers can create new types of zeolites, for example with pore sizes suited to specific types of filtration.

    All kinds of zeolites are silicate minerals, similar in chemical composition to quartz. In fact, over geological timescales, they will all eventually turn into quartz — a much denser form of the mineral — explains Gomez-Bombarelli, who is the Toyota Assistant Professor in Materials Processing. But in the meantime, they are in a “metastable” form, which can sometimes be transformed into a different metastable form by applying heat or pressure or both. Some of these transformations are well-known and already used to produce desired zeolite varieties from more readily available natural forms.

    Currently, many zeolites are produced by using chemical compounds known as OSDAs (organic structure-directing agents), which provide a kind of template for their crystallization. But Gomez-Bombarelli says that if instead they can be produced through the transformation of another, readily available form of zeolite, “that’s really exciting. If we don’t need to use OSDAs, then it’s much cheaper [to produce the material].The organic material is pricey. Anything we can make to avoid the organics gets us closer to industrial-scale production.”

    Traditional chemical modeling of the structure of different zeolite compounds, researchers have found, provides no real clue to finding the pairs of zeolites that can readily transform from one to the other. Compounds that appear structurally similar sometimes are not subject to such transformations, and other pairs that are quite dissimilar turn out to easily interchange. To guide their research, the team used an artificial intelligence system previously developed by the Olivetti group to “read” more than 70,000 research papers on zeolites and select those that specifically identify interzeolite transformations. They then studied those pairs in detail to try to identify common characteristics.

    What they found was that a topological description based on graph theory, rather than traditional structural modeling, clearly identified the relevant pairings. These graph-based descriptions, based on the number and locations of chemical bonds in the solids rather than their actual physical arrangement, showed that all the known pairings had nearly identical graphs. No such identical graphs were found among pairs that were not subject to transformation.

    The finding revealed a few previously unknown pairings, some of which turned out to match with preliminary laboratory observations that had not previously been identified as such, thus helping to validate the new model. The system also was successful at predicting which forms of zeolites can intergrow — forming combinations of two types that are interleaved like the fingers on two clasped hands. Such combinations are also commercially useful, for example for sequential catalysis steps using different zeolite materials.

    Ripe for further research
     

    The new findings might also help explain why many of the theoretically possible zeolite formations don’t seem to actually exist. Since some forms readily transform into others, it may be that some of them transform so quickly that they are never observed on their own. Screening using the graph-based approach may reveal some of these unknown pairings and show why those short-lived forms are not seen.

    Some zeolites, according to the graph model, “have no hypothetical partners with the same graph, so it doesn’t make sense to try to transform them, but some have thousands of partners” and thus are ripe for further research, Gomez-Bombarelli says.

    In principle, the new findings could lead to the development of a variety of new catalysts, tuned to the exact chemical reactions they are intended to promote. Gomez-Bombarelli says that almost any desired reaction could hypothetically find an appropriate zeolite material to promote it.

    “Experimentalists are very excited to find a language to describe their transformations that is predictive,” he says.

    This work is “a major advancement in the understanding of interzeolite transformations, which has become an increasingly important topic owing to the potential for using these processes to improve the efficiency and economics of commercial zeolite production,” says Jeffrey Rimer, an associate professor of chemical and biomolecular engineering at the University of Houston, who was not involved in this research.

    Manuel Moliner, a tenured scientist at the Technical University of Valencia, in Spain, who also was not connected to this research, says: “Understanding the pairs involved in particular interzeolite transformations, considering not only known zeolites but also hundreds of hypothetical zeolites that have not ever been synthesized, opens extraordinary practical opportunities to rationalize and direct the synthesis of target zeolites with potential interest as industrial catalysts.”

    << Previous Day 2019/10/07
    [Calendar]
    Next Day >>

MIT Research News   About LJ.Rossia.org